Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era

Cancer

Volumn 118, Issue 17, 2012, Pages 4166-4172

  Takahashi, Hiroyuki ^a   Tomita, Naoto ^a   Yokoyama, Masahiro ^b   Tsunoda, Saburo ^c   Yano, Takahiro ^d   Murayama, Kayoko ^e   Hashimoto, Chizuko ^f   Tamura, Kazuo ^g   Sato, Kazuya ^h   Ishigatsubo, Yoshiaki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c TOCHIGI CANCER CENTER   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION   (Japan)

^e GUNMA UNIVERSITY   (Japan)

^f KANAGAWA CANCER CENTER   (Japan)

^g FUKUOKA UNIVERSITY   (Japan)

^h JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

diffuse large B cell lymphoma; extranodal site; rituximab; Waldeyer ring

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TISSUE DISTRIBUTION; WALDEYER RING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; VINCRISTINE; YOUNG ADULT;

EID: 84865326263     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27381     Document Type: Article

References (14)

1. Shipp MA,. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993; 329: 987-994.
2. Coiffier B,. State-of-the-art therapeutics: diffuse large B-cell lymphoma. J Clin Oncol. 2005; 23: 6387-6393.
3. Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007; 109: 1857-1861.
4. Tomita N, Yokohyama M, Yamamoto W, et al. Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era. Cancer Sci. [published online ahead of print November 2, 2011.]
5. Vega F, Padula A, Valbuena JR, et al. Lymphomas involving the pleura: a clinicopathologic study of 34 cases diagnosed by pleural biopsy. Arch Pathol Lab Med. 2006; 130: 1497-1502.
6. Nakamura S, Matsumoto T, Takeshita M, et al. A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Cancer. 2000; 88: 286-294.
7. Weng SC, Wu CY,. Lymphoma presenting as peritoneal lymphomatosis with ascites. J Chin Med Assoc. 2008; 71: 646-650.
8. Mozos A, Ye H, Chuang WY, et al. Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod Pathol. 2009; 22: 1210-1217.
9. Yan Y, Chan WC, Weisenburger DD, et al. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol. 1995; 13: 1336-1342.
10. Mazloom A, Fowler N, Medeiros LJ, et al. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience. Leuk Lymphoma. 2010; 51: 1217-1224.
11. Zucca E, Conconi A, Mughal TI, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003; 21: 20-27.
12. Yamamoto W, Naoto T, Reina W, et al. Central nervous system involvement in diffuse large B-cell lymphoma. Eur J Hematol. 2010; 85: 6-10.
13. Lopez-Guillermo A, Colomo L, Jimenez M, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol. 2005; 23: 2797-2804.
14. Qi SN, Li YX, Wang H, et al. Diffuse large B-cell lymphoma: clinical characterization and prognosis of Waldeyer ring versus lymph node presentation. Cancer. 2009; 115: 4980-4989.